A Clinical Study of TQB2450 Combined With Anlotinib in Limited-Stage Small Cell Lung Cancer Patients
Clinical trial NCT06469879 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT06469879
- Sponsor
- Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2024-09-01
- Primary completion
- 2026-09-01
- Enrollment
- 358
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.